Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

microbiota-based formulation RBX7455

An orally administered, microbiota-based therapeutic composed of a processed and lyophilized form of the microbiota suspension RBX2660, consisting of live, human-derived bacteria prepared from donated human stool, with potential immunomodulatory activity. Upon administration, microbiota-based formulation RBX7455 may restore the unhealthy, altered gut microbiome, enhance the microbial diversity and function in the gastrointestinal (GI) tract and may re-establish a healthy microbiome in the GI tract. This may enhance the patients' immunological activity.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Code name:	RBX 7455 RBX-7455

microbiota-based formulation RBX7455

Search NCI's Drug Dictionary